Hardman & Co Research | WebDisclosure

Basculer en Français

9480	Companies
185559	Keywords
117951	Articles
99390	Press releases

Headlines Articles Press releases Hardman & Co Research

Home
Companies
Hardman & Co Research

BRIEF

published on 01/28/2025 at 12:45, 10 months 8 days ago

ICG Enterprise Trust's Strategic Capital Allocation

Private Equity Share Buyback ICG Enterprise Trust Dividend Capital Allocation
PRESS RELEASE

published on 01/28/2025 at 12:40, 10 months 8 days ago

Hardman & Co Research on ICG Enterprise Trust plc: Unique approach to capital allocation
Hardman & Co Research examines ICG Enterprise Trust plc's unique approach to capital allocation, rewarding investors with progressive dividend, compounding growth, and NAV accretion

Hardman & Co Research Capital Allocation ICG Enterprise Trust Plc Progressive Dividend NAV Accretion
BRIEF

published on 01/09/2025 at 10:25, 10 months 27 days ago

Chesnara's New Acquisition from Canada Life UK

Chesnara Acquisition Canada Life UK Unit-linked Bonds Legacy Pension Business Countrywide Assured
BRIEF

published on 01/09/2025 at 10:25, 10 months 27 days ago

Nouvelle acquisition de Chesnara auprès de Canada Life UK

Acquisition De Chesnara Canada Life Royaume-Uni Obligations En Unités De Compte Entreprise De Retraite Héritée Garantie À L'échelle Nationale
PRESS RELEASE

published on 01/09/2025 at 10:20, 10 months 27 days ago

Hardman & Research on Chesnara plc: Happy new acquisition
Chesnara plc announces acquisition of portfolio from Canada Life UK, worth £1.5bn AUM. Positive step for the company. Integration expected to be straightforward

Acquisition Portfolio Chesnara Plc AUM Canada Life UK
BRIEF

published on 11/21/2024 at 12:20, 1 year ago

Shield Therapeutics Focuses on Cash Management to Reach Breakeven

Cash Management Shield Therapeutics Accrufer® Iron Deficiency Breakeven Strategy
BRIEF

published on 11/21/2024 at 12:20, 1 year ago

Shield Therapeutics se concentre sur la gestion de trésorerie pour atteindre le seuil de rentabilité

Accrufer® Carence En Fer Thérapeutique Shield Gestion De Trésorerie Stratégie D'équilibre
PRESS RELEASE

published on 11/21/2024 at 12:15, 1 year ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven. Shield Therapeutics increasing physician awareness for ACCRUFeR® sales traction

Hardman & Co Cash Management Shield Therapeutics Iron Deficiency Pharma Company
BRIEF

published on 11/20/2024 at 11:35, 1 year ago

Duke Capital's Equity Raise and Third-Party Capital Initiatives

Risk Management Equity Raise Financial Strategy DUKE Capital Third-Party Capital
BRIEF

published on 11/20/2024 at 11:35, 1 year ago

Augmentation de capital et initiatives de financement par des tiers de Duke Capital

Stratégie Financière Augmentation De Capital Gestion Des Risques Capitale Du Duc Capitaux De Tiers

Accesswire

Published on 12/05/2025 at 21:45, 1 hour 13 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 28 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 1 hour 38 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 58 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 2 hours 33 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 42 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 46 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 4 hours 31 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 4 hours 42 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 17:18, 5 hours 40 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 5 hours 40 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 7 hours 47 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 7 hours 47 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 59 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE